Literature DB >> 32032256

THE RAP STUDY, REPORT TWO: The Regional Distribution of Macular Neovascularization Type 3, a Novel Insight Into Its Etiology.

Bilal Haj Najeeb1, Gabor Deak, Ursula Schmidt-Erfurth, Bianca S Gerendas.   

Abstract

PURPOSE: To explore the regional distribution of macular neovascularization type 3 (MNV3).
METHODS: Seventy-eight eyes of 78 patients were reviewed. We defined the location of each lesion after applying a modified ETDRS grid and the incidence of simultaneous MNV1 or 2. Also, we investigated the distribution of MNV3 at the outline of the foveal avascular zone and when the diameter of foveal avascular zone was less than 325 µm.
RESULTS: The distribution of MNV3 was 4 lesions (5%) from the center to 500 µm, 72 (92%) from 500 µm to 1500 µm, and 2 (3%) from 1,500 µm to 3000 µm. The distribution in respect of the ETDRS fields was 7 (9%) nasal, 16 (20%) superior, 32 (40%) temporal, and 23 (31%) inferior. No additional MNV1 or 2 were found elsewhere. Most lesions tended to distribute along straight bands radiating from the perifoveal area, mainly in the temporal half (72%). None of the cases had MNV3 at the boundary of the foveal avascular zone. Only five cases had foveal avascular zone diameter of less than 325 µm, the closest lesion was 425 µm away from the center.
CONCLUSION: MNV3 lesions are most likely neither symmetrical nor uniformly distributed. They have a higher affinity to distribute radially in the temporal perifoveal area.

Entities:  

Year:  2020        PMID: 32032256     DOI: 10.1097/IAE.0000000000002774

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  6 in total

1.  Do patients with unilateral macular neovascularization type 3 need AREDS supplements to slow the progression to advanced age-related macular degeneration?

Authors:  Bilal Haj Najeeb; Ursula Schmidt-Erfurth
Journal:  Eye (Lond)       Date:  2022-09-29       Impact factor: 4.456

2.  The RAP study, report 3: Discoloration of the macular region in patients with macular neovascularization type 3.

Authors:  Bilal Haj Najeeb; Gabor G Deak; Ursula Schmidt-Erfurth; Bianca S Gerendas
Journal:  Acta Ophthalmol       Date:  2021-04-05       Impact factor: 3.988

3.  Biometrics, Impact, and Significance of Basal Linear Deposit and Subretinal Drusenoid Deposit in Age-Related Macular Degeneration.

Authors:  Ling Chen; Jeffrey D Messinger; Deepayan Kar; Jacque L Duncan; Christine A Curcio
Journal:  Invest Ophthalmol Vis Sci       Date:  2021-01-04       Impact factor: 4.799

4.  The RAP study, report 4: morphological and topographical characteristics of multifocal macular neovascularization type 3.

Authors:  Bilal Haj Najeeb; Gabor G Deak; Stefan Sacu; Ursula Schmidt-Erfurth; Bianca S Gerendas
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-08-26       Impact factor: 3.117

5.  Spatial Dissociation of Subretinal Drusenoid Deposits and Impaired Scotopic and Mesopic Sensitivity in AMD.

Authors:  Yuhua Zhang; SriniVas R Sadda; David Sarraf; Thomas A Swain; Mark E Clark; Kenneth R Sloan; William E Warriner; Cynthia Owsley; Christine A Curcio
Journal:  Invest Ophthalmol Vis Sci       Date:  2022-02-01       Impact factor: 4.799

6.  Longitudinal Analysis of Structural and Functional Changes in Presence of Reticular Pseudodrusen Associated With Age-Related Macular Degeneration.

Authors:  Marlene Sassmannshausen; Maximilian Pfau; Sarah Thiele; Rolf Fimmers; Julia S Steinberg; Monika Fleckenstein; Frank G Holz; Steffen Schmitz-Valckenberg
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-08-03       Impact factor: 4.799

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.